Rehmannioside D is an orally active Sirt7 modulator. Rehmannioside D upregulates Sirt7 expression, inhibits the level of acetylated p53, and blocks the activation of the p53 signaling pathway. Rehmannioside D alleviates liver injury, inflammatory response, collagen deposition and hepatocyte apoptosis. Rehmannioside D is applicable to research related to liver fibrosis[1][2].
Molekulargewicht:
686.61
Reinheit:
99.89
CAS Nummer:
[81720-08-3]
Formel:
C27H42O20
Target-Kategorie:
Apoptosis,Bcl-2 Family,Caspase,MDM-2/p53,Reactive Oxygen Species (ROS),Sirtuin
Anwendungsbeschreibung:
MCE Product type: Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten